ViaDerma, Inc. (VDRM)

ViaDerma Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2017	FY 2016	FY 2015	FY 2011	FY 2010
Period Ending	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2011	Dec 31, 2010
Revenue	0.04	0.25	0.19	19.01	26.83
Revenue Growth (YoY)	-82.26%	31.39%	-98.99%	-29.15%	6.20%
Cost of Revenue	0.01	0.01	0.02	13.35	16.68
Gross Profit	0.04	0.24	0.18	5.66	10.15
Selling, General & Admin	0.49	0.11	0.04	1.62	2.38
Operating Expenses	0.63	0.11	0.08	1.62	2.38
Operating Income	-0.59	0.13	0.09	4.04	7.77
Interest Expense	-0.39	-0.25	-0.12	-0.5	-1.27
Interest & Investment Income	-	-	-	0.01	0
Other Non Operating Income (Expenses)	-0.53	-0.02	0.05	-	-
EBT Excluding Unusual Items	-1.52	-0.14	0.03	3.55	6.5
Gain (Loss) on Sale of Assets	-	-	-	-0	-0
Other Unusual Items	-	0.02	-	-	-
Pretax Income	-1.52	-0.12	0.03	3.55	6.5
Income Tax Expense	-	-	-	0.87	1.99
Net Income	-1.52	-0.12	0.03	2.67	4.51
Net Income to Common	-1.52	-0.12	0.03	2.67	4.51
Net Income Growth	-	-	-98.98%	-40.70%	10.07%
Shares Outstanding (Basic)	376	161	104	0	0
Shares Outstanding (Diluted)	376	161	104	0	0
Shares Change (YoY)	133.98%	55.10%	75400.79%	-	-0.76%
EPS (Basic)	-0.00	-0.00	0.00	19.46	32.82
EPS (Diluted)	-0.00	-0.00	0.00	19.46	32.82
EPS Growth	-	-	-100.00%	-40.70%	11.25%
Free Cash Flow	-0.17	-0.01	-0.01	-3.38	0.65
Free Cash Flow Per Share	-	-	-	-24.60	4.74
Gross Margin	84.20%	95.74%	91.66%	29.79%	37.82%
Operating Margin	-1327.78%	50.58%	48.88%	21.25%	28.95%
Profit Margin	-3397.52%	-48.34%	14.14%	14.06%	16.80%
Free Cash Flow Margin	-374.49%	-4.79%	-5.83%	-17.77%	2.43%
EBITDA	-0.59	0.13	0.09	6.85	9.33
EBITDA Margin	-	50.96%	49.39%	36.02%	34.76%
D&A For EBITDA	0	0	0	2.81	1.56
EBIT	-0.59	0.13	0.09	4.04	7.77
EBIT Margin	-	50.58%	48.88%	21.25%	28.95%
Effective Tax Rate	-	-	-	24.65%	30.66%
Revenue as Reported	0.04	0.25	0.19	-	-
Advertising Expenses	0.01	-	0.01	-	-

Updated May 3, 2018. Source: S&P Global Market Intelligence. Standard template. Financial Sources.